In the Press

New UC Riverside research shows fungi and bacteria able to survive redwood tanoak forest megafires are microbial "cousins" that often increase in abundance after feeling the flames.

In this study, Klebsiella pneumoniae was suspended in synthetic saliva in a nebulizer (N0) and nebulized for 5 min (N5) into an aerosol chamber and further prolonged in the aerosolization phase for 15 min (A15) under four different conditions

New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April) found that most women who catch COVID-19 when pregnant pass antibodies to their unborn babies.

This Special Issue mainly focuses on investigating and reinforcing the role of aerosol transmission of SARS-CoV-2 as the predominant driver of the COVID-19 pandemic. Both modeling and experimental methods are widely used.

Population-based estimates for both type 1 and type 2 diabetes in low-income and middle-income countries are imprecise because of the paucity of registration and surveillance systems in these settings.

Up to 12,000 substances could fall within the scope of the new ‘restrictions roadmap Thousands of potentially harmful chemicals could soon be prohibited in Europe under new restrictions, which campaigners have hailed as the strongest yet.

Legionella bacteria are commonly found in facility water systems. Left unchecked, they can cause serious disease and even death.

A team of researchers from Genentech, Inc., the Howard Hughes Medical Institute and the Peter MacCallum Cancer Center, has found that cancerous tumor cells are able to survive attacks by repairing holes in their membranes caused by a protein released from T cells.

New Mexico Gov. Michelle Lujan Grisham has signed emergency declarations as 20 wildfires continued to burn Sunday in nearly half of the state's drought-stricken 33 counties.

Scientists from an international consortium led by Dr. Eduard Batlle, head of the Colorectal Cancer laboratory at IRB Barcelona, ICREA researcher and group leader of CIBER de Cáncer (CIBERONC), together with the Dutch company Merus N.V., reveal the preclinical data that has led to the discovery of MCLA-158 and its mechanism of action on cancer stem cells.